EP4583945A1 — Dosing apparatus for parenteral delivery of fluids
Assigned to SHL Medical AG · Expires 2025-07-16 · 1y expired
What this patent protects
A dosing apparatus (100) for parenteral delivery of at least two fluids, the dosing apparatus comprising a dosing actuating unit (200) configured to actuate delivery of one of the at least two fluids, and at least two dosing delivery devices (300), each dosing delivery device com…
USPTO Abstract
A dosing apparatus (100) for parenteral delivery of at least two fluids, the dosing apparatus comprising a dosing actuating unit (200) configured to actuate delivery of one of the at least two fluids, and at least two dosing delivery devices (300), each dosing delivery device comprising a chamber (310) extending along an axis A comprising at least one intake opening (320) and at least one outlet opening (330), a first and a second piston (340, 350), wherein said first and second pistons are displaceable along the axis A within the chamber; and wherein the chambers of the at least two dosing delivery devices are configured to each hold a fluid, such that a rotational movement of the dosing actuating unit delivers the fluids.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.